Significant changes in gut bacteria were observed in patients with Multiple Sclerosis within a month of treatment with ocrelizumab, a small, ongoing study reports.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read full article on


Follow Us on Twitter

Follow Us On Twitter - Image